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Wave We Really Come to
nderstand the Relationship
etween the Left Ventricular
utflow Tract Gradient and
eft Ventricular Emptying in
ypertrophic Cardiomyopathy?
n the recent review of hypertrophic cardiomyopathy (HCM) by
aron et al. (1), historical controversies relating to the relationship
etween left ventricular outflow tract (LVOT) pressure gradients
nd left ventricular (LV) ejection dynamics are revisited. The crux
f these controversies is an assumption that the very presence of
uch gradients negatively impacts LV emptying (outflow) in
bstructive HCM.
Maron et al. (1) point to earlier studies in which LV emptying
nd aortic volumetric flow were shown to be rapid and fairly
omplete by midsystole, whether a gradient was present or not
2–5). Furthermore, even in the same patient, LV emptying was
hown to be faster in cardiac cycles in which gradients were present
ompared with those in which they were absent (3,6). The
nvestigators of those studies concluded that an LVOT gradient
as not associated with an impediment to LV emptying. Maron
t al. (1) state that these conclusions were subsequently proven to
e invalid, but cite a study that never investigated LV emptying or
ortic flow in volumetric terms (7).
Unfortunately, much of this lack of agreement derives from the
act that we often use, in discussing hemodynamics, colloquial
erms that have no rigorous mathematical or physical definitions in
he field of physics or its subdiscipline of fluid dynamics. For
xample, the terms obstruct or impede are not found in the
hysical sciences. Surely, one can find them defined in dictionaries:
to block or fill (a passage) with obstacles . . .” or “to impede,
etard, or interfere with; hinder (sic) progress. . . .” (8). However,
uch terms are subjective and are not defined by quantitative
hysical measurements.
Another major problem in these debates has been the difficulty
hat most clinical cardiologists have in understanding the physical
elationships between pressure gradients and flow. We were all
rained in the resistance concept of Poiseuille’s law, in which
orward flow is always associated with a positive pressure gradient.
owever, this concept is only a small part of the physics of pressure
nd flow, in which the additional impact of inertial and convective
cceleration components plays a major role and the significance of
ressure gradients is more completely understood (9).
So, what does the term outflow obstruction mean? Where has it
ver been actually defined so that all participants in these debates
re operating from the same platform? Unfortunately, no rigorous
efinition exists. This has resulted in confusion, semantic differ-
nces, and much misunderstanding. bIf one examines the issue of obstruction from a muscle mechan-
cs viewpoint, the presence of marked LVOT gradients must result
n inappropriate endocardial wall stress, which can lead to exacer-
ation of the diastolic abnormalities that underlie many of the
ongestive symptoms in HCM. However, from a pump function
tandpoint, where LV volume or aortic volumetric flow is actually
easured as a function of time through systole, there is no
vidence that outflow is compromised as a result of an LVOT
radient.
Such an understanding does not imply that elimination of
VOT gradients is not potentially beneficial. Rather, one hopes
hat when one does recommend an intervention to eliminate such
radients, one understands that that intervention is not designed to
mprove ejection itself.
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eply
e appreciate the correspondence from Dr. Murgo, stimulated
y our recent historical review focused on the evolving under-
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February 9, 2010:608–11tanding of left ventricular (LV) outflow gradients in hypertro-
hic cardiomyopathy (HCM) (1). Dr. Murgo has had an
mportant role in this conversation, which has spanned virtually
he last 5 decades (2), for this heterogeneous disease with
omplex ejection dynamics (1,3).
However, on the issue of whether obstruction represents true
echanical impedance we must depart sharply from ideas reso-
utely held by Dr. Michael Criley in the 1960s, which we believe
ave plagued the contemporary understanding of HCM and its
anagement, that is, that somehow LV outflow gradients are
ncidental to this disease and are not responsible for heart failure
ymptoms that disable many patients.
We would like to take this opportunity fortuitously afforded by
r. Murgo’s letter to once again underscore a crucial principle in
CM, that is, subaortic gradients due to mitral valve systolic
nterior motion represent true mechanical obstruction to LV
utflow and are responsible for high intraventricular pressures and
ncreased wall stress, which (in association with mitral regurgita-
ion) lead to exertional dyspnea and physical limitation compro-
ising quality of life.
Fifty years after the initial description of HCM (1), evidence for
he clinical significance of true obstruction to outflow in HCM is
verwhelming, having recently been demonstrated in large cohorts
ollowed up for long periods of time (1,4,5). Relief of LV outflow
bstruction by surgical septal myectomy (or selectively by alcohol
blation) has been shown repeatedly to relieve heart failure
ymptoms, and in the case of myectomy, to enhance long-term
urvival (5). Indeed, this is not unlike the clinical experience with
bstruction due to aortic valve stenosis, albeit with different
jection dynamics.
The present discussion is reminiscent of the “second HCM
bstruction debate” 25 years ago at the American College of
ardiology meeting (1) when Dr. Murgo lectured passionately
bout the nuances of LV ejection dynamics and nomenclature, but
n the process may not have addressed the essential clinical
essage, that is, that outflow gradients (and secondary mitral
egurgitation) are associated with substantially elevated LV systolic
and diastolic) pressures, which can cause disabling symptoms but
re mechanically reversible by septal reduction intervention and
ith resultant restoration of quality of life and longevity.
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eterminants of
unctional Capacity in
eripheral Arterial Disease
n their excellent paper, Anderson et al. (1) showed that cellular
etabolism correlated better with treadmill exercise results than
stimation of muscle perfusion in patients with peripheral artery
isease (PAD). Anderson et al. (1) suggested that factors inde-
endent of blood flow and located downstream from the obstruc-
ion are believed to play an important role in the relative absence
f relation of the degree of hemodynamic impairment to functional
imitation. Why should only downstream vascular parameters be
actors to play a role in this result?
First, in the accompanying editorial, Dewey (2) briefly recalls
hat PAD may affect various arterial territories (among which the
elvic circulation) further limiting their clinical prognosis. In
erspective with the high prevalence (22%) of patients with prior
evascularization among the 85 studied patients, it is likely that
unctional limitation from proximal claudication may have inter-
ered with the expected relationship between calf perfusion and
xercise capacity. Indeed, proximal claudication may persist in
pproximately one-third of PAD patients early after aortobifemo-
al bypass surgery (3) or be present in a comparable proportion in
hose who have a patent aortobifemoral bypass with a median delay
f 2 years from surgery (4). In these patients as well as those with
solated occlusion of the internal iliac artery, PAD may result in
evere functional impairment whereas distal (calf) perfusion is not
mpaired.
Second, many studies have underlined that the impairment of
erobic and anaerobic capacity is significantly correlated with the
everity of anemia. Although blood samples were available in the
tudy of Anderson et al. (1) for cholesterol estimation and
nflammatory markers, the evaluation of hemoglobin content is not
eported. Anemia is a common comorbid condition in elderly
atients. Of 732 consecutive patients admitted to an acute geriatric
ard, 24% were found to be anemic (5). The proportion of anemic
atients may even be higher in patients with advanced PAD (6).
Lastly, limb pain while walking may be the sole reported
ymptom of exercise-induced hypoxemia (7). Respiratory param-
ters at rest may remain in normal limits despite the presence of
xercise-induced hypoxemia. Pulmonary disease and vascular dis-
ase share a number of common risk factors (age, overweight,
obacco). Not all patients with pulmonary disease have hypoxemia,
ut 15% of patients with PAD (8,9) have pulmonary disease.
herefore, exercise-induced hypoxemia may be a frequent aggra-
ating cause of exercise intolerance in PAD patients.
